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INFLUENZA & PERTUSIS: PREGNANT & NEWBORN CONCERNS  
Pertussis and influenza are prominent, common infections with more 
than 15,000 and 50,000,000 annual U.S. cases respectively.1,2  Compared 
to the general population, pregnant patients and newborns are more 
susceptible to infection complications. For example, pregnant patients 
with influenza have higher risks of ICU admission, pneumonia 
progression, and adverse perinatal outcomes.3 Infants under 6 months 
are more susceptible to infections due to their incomplete, developing 
immune system. In fact, majority of morbidity and mortality attributed 
to pertussis infection occurs in infants 3 months or younger.4 
Furthermore, the earliest recommended vaccination age for influenza is 
6 months; for pertussis, 2 months – leaving a considerable window of 
vulnerability.5 
VACCINATION RECOMMENDATION: PREGNANT PATIENTS 
According to the Advisory Committee on Immunization Practices 
(ACIP), it is critical and recommended for pregnant patients to receive 
annual influenza (flu) vaccine and Tetanus, diphtheria, pertussis (Tdap) 
vaccine every pregnancy, irrespective of prior history. The influenza 
immunization of pregnant patients can decrease risk of infection and 
accompanying complications. With both flu and Tdap immunizations, 
pregnant patients not only can “cocoon” their newborns by preventing 
infection spread but can also passively transfer their antibodies to their 
infants to cover their window of vulnerability.3,4 Because of the 
importance of flu and Tdap vaccines in pregnancy and their established 
use safety,6 previous studies have investigated barriers to vaccine 
uptake in pregnant populations. Miseducation and fear of harm from 
vaccines present major barriers to vaccine uptake,7,8 and race, number of 
provider visits, provider vaccine recommendation, and parity may also 
be predictors of vaccine uptake.8,9,10 
The purpose of this study was to find ways to improve flu and Tdap 
vaccination rates in pregnant patients at the University of Tennessee 
Family Medicine Clinic at Memphis (UTFMC-M).  The research 
questions were the following: At UTFMC-M,
1. What were the age, race, and insurance of the patient sample?
2. What were the flu & Tdap vaccination rates in eligible pregnant 
patients?  
3. How did the UTFMC-M vaccination rates compare to national 
vaccination rates?
4. Were there trends that may indicate barriers to vaccine uptake 
(physician encouragement, number of prenatal visits, trimester age 
at first prenatal visit, high risk clinic status (HRC), parity, age)?
● A query search of all UTFMC-M patients was performed to identify 
any patients who were pregnant from September 1, 2019 -April 24, 
2020 (included the 2019-2020 flu season). n= 465.
● Data was extracted from the NextGen Enterprise EMR system. 
● Inclusion/exclusion criteria: Flu and Tdap vaccine eligibility based on 
ACIP recommendations included Flu shot eligible patients = any 
gestation age (0-41 weeks); Tdap eligible patients = ≥27 weeks. ≥2 
visits to the UTFMC-M High Risk Clinic (HRC), a clinic that specifies 
in high risk pregnant patient care, was noted as positive HRC 
admittance status. 
● IBM SPSS 26 was used for all statistics.
● Chi-square independence and Mann-Whitney U tests were run to 
determine the relationship between vaccination rates and the 
variables of interest. 
● A 95% CI was approximated by calculating 2 standard errors for the 
upper and lower limits to compare clinic vaccination rates to 
national vaccination rates. 
The U.S. Department of Health & Human Services goal for influenza 
immunization during pregnancy is 80%.11 The Centers for Disease 
Control & Prevention recommend that all pregnant patients receive the 
Tdap vaccine ideally between 27-36 weeks gestation.12 Based on these 
and on our study’s findings we recommend the following:
● Continue to encourage vaccination at every visit.
● Continue booking multiple visits (8 for flu, 9 for Tdap). 
● Try to prioritize Tdap vaccination higher on problem list for those 
who are late prenatal patients.
● Focus on flu vaccine encouragement and education. 
Previous rate improvement measures have focused on addressing the 
issues of miseducation, fear of harm to the baby,⁷ and physician vaccine 
encouragement9,10 through the following strategies:7,13
1. Provide educational updates to physicians on vaccination during 
pregnancy from the Assistant Secretary for Health.
2. Educate patients about vaccine safety and efficacy.9
3. Provide quarterly clinic rate reports to all healthcare staff.
4. Create standing orders for vaccine encouragement by all providers.
5. Train nurses on encouraging vaccination and taking initiative in 
helping complete immunization for eligible patients.14
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Fig. 3a: Relationship Between Vaccination Uptake & Physician Encouragement 
Figure 5: Relationship between Trimester at first visit & Tdap Vaccination Status
There was a significant relationship, X2 (6, N = 465) =47.635 , 
p<0.001. 56.8% of patients that received the Tdap vaccine (n=234) 
were in Trimester 1 (T1) at the first prenatal visit.
STUDY LIMITATIONS
● US vs. UTFMC-M rates: The US and UTFMC-M samples were likely 
not equivalent: UTFMC-M sample was predominantly black and 
Medicaid insured; the national study sample, more diverse.8
Additionally, UTFMC-M rates among patients who delivered could 
not directly compare with US rates among patients who delivered 
live births. Thus the comparison was only a preliminary exploration 
of the data.
● Physician Encouragement: EMR did not state encouragement status.  
All vaccinated patients and those who declined, both factors 
specifically documented in EMR notes by physician, were assumed 
to have received physician encouragement.
● Multiple comparisons (esp. a posteriori) may increase error rates. 
However, the current study consisted of a priori comparisons, which 
are theoretically acceptable for preliminary data exploration. 
There was a significant difference (U=4599.5, p<0.001) in number of 
prenatal visits between the vaccinated group (M=9) and not 
vaccinated group (M=4).
SUMMARY
● UTFMC-M vaccine rates were on par with U.S. flu vaccine rates and 
higher than U.S. Tdap and Tdap & Flu (“both”) vaccination rates.
● There were statistically significant relationships between vaccine 
uptake at UTFMC-M and physician encouragement, number of 
prenatal visits, and trimester age at first prenatal visit.
● There were no significant relationships between vaccine uptake and 
UTFMC-M HRC admittance for high risk pregnancies, parity, or age. 
RESULTS
There  was a positive relationship, X2 (1, N = 465) =131, p < 0.001, between 
physician encouragement of the flu vaccine and uptake.
Fig. 3b: Relationship Between Vaccination Uptake & Physician Encouragement
Q1 ANSWER: UTFMC-M PREGNANT PATIENT PREDOMINANT DEMOGRAPHIC
● Age: 26.6 years (mode).
● Race: 84.3% Black (8.2% White, 3.2% Hispanic, 0.9% Asian, 0.4% 
American Indian/Alaskan Native, 0.6% other, 2.4% unlisted). 
● Insurance: 88% insured by Tenncare (Medicaid) (9.2% commercial, 
1.1% self-pay). 
Q2 ANSWER: UTFMC-M VACCINATION RATES 
● Flu (Fig. 1): Among pregnant eligible patients (any gestation age, 
n=465), 50.1% were flu-vaccinated. 
● Tdap (Fig. 1): Among pregnant eligible patients (≥27 weeks, n=317), 
73.8% were Tdap-vaccinated. 
● Both (Fig. 1): Among pregnant Tdap & Flu eligible patients (≥27 
weeks, n=317), 52.1% were Flu & Tdap-vaccinated. 
Fig. 4a: Comparing Prenatal Visits & Flu Uptake Fig. 4b: Comparing Prenatal Visits & Tdap Uptake
Fig. 1: UTFMC-M Vaccination Rates 
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There was a significant difference (U=17467.5, p< 0.001) in number of 
prenatal visits between the vaccinated group (M = 8) and not vaccinated 
group (M=4).
U.S. national survey pregnant sample 
from 2018-2019 flu season.8 UTFMC-
M pregnant sample (2019-2020). The 
samples compared may not be 
equivalent. p=0.05. 
U.S. national survey pregnant subgroup who 
delivered live births in the 2018-2019 flu season.8  
UTFMC-M pregnant subgroup who delivered in 
query timeframe (2019-2020). The samples 
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Q3 ANSWER: US VS. UTFMC-M VACCINATION RATES 
● Flu (Fig. 2a): The national rate (53.7%)8 was within the UTFMC-M flu 
rate 95% confidence interval (50.1%, 95% CI: 45.5-54.7%, p=0.05). 
● Tdap (Fig. 2b): The UTFMC-M rate among patients who delivered 
(79.9%, 95% CI: 74.4-85.4%, p=0.05) was higher than the national rate 
(54.9%, among those who delivered live births).8 
● Both (Fig. 2b): The UTFMC-M rate among patients who delivered 
(56.0%, 95% CI: 49.1-62.8%, p=0.05) was higher than the national rate 
(34.8%, among those who delivered live births).8
Q4 ANSWER: RELATIONSHIPS BETWEEN VACCINATION & VARIABLES OF INTEREST
No significant associations were found between vaccination and HRC 
status, Parity, and Age. However, statistically significant relationships 
were found among the below variables:
● Physician Encouragement 
○ There was a positive relationship between encouragement and 
vaccination (Fig. 3).
○ There was a positive relationship between Flu vaccine 
encouragement and Tdap vaccination, X2 (3, N = 465) =96.994, p < 
0.001; between Tdap encouragement and flu vaccination, X2 (2, N
= 465) =61.9, p < 0.001.
● Number of Prenatal Visits 
○ Mean rank no. of visits in those who were vaccinated was higher 
than those who were not vaccinated (Fig. 4).
○ The flu-vaccinated group had a median of 8 visits; Tdap-
vaccinated group, 9 visits; unvaccinated patients, 4 visits (Fig. 4). 
● Trimester age at 1st prenatal visit 
○ There was a relationship between trimester age at 1st prenatal 
visit and Tdap vaccination only (Fig. 5).
○ 56.8% of Tdap-vaccinated patients were in trimester 1 at the first 
visit; smaller proportions of vaccinated patients were in later 
trimesters (Fig. 5).
There was a positive relationship, X2 (6, N = 465) =476, p < 0.001, between 
physician encouragement and Tdap uptake.
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